Wilmink JM - Search Results

1

Serum neopterin/creatinine values correlate with severity of symptoms caused by cytomegalovirus infection in renal transplant recipients.

Raasveld MH, Bloemena E, Wertheim-van Dillen P, Surachno J, Wilmink JM, ten Berge IJ. Raasveld MH, et al. Among authors: wilmink jm. Transpl Int. 1993 Jan;6(1):42-4. doi: 10.1007/BF00336639. Transpl Int. 1993. PMID: 8383975

2

Serum levels of soluble CD27 in renal transplant recipients.

Chamuleau ME, ten Berge IJ, Schellekens PT, Wilmink JM, Hintzen RQ, van Lier RA. Chamuleau ME, et al. Among authors: wilmink jm. Transplantation. 1992 Nov;54(5):932-6. Transplantation. 1992. PMID: 1332227 No abstract available.

3

Kinetics of interleukin 6 during OKT3 treatment in renal allograft recipients.

Bloemena E, ten Berge IJ, Surachno J, Wilmink JM. Bloemena E, et al. Among authors: wilmink jm. Transplantation. 1990 Aug;50(2):330-1. Transplantation. 1990. PMID: 2143327 No abstract available.

4

Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients.

Parlevliet KJ, Bemelman FJ, Yong SL, Hack CE, Surachno J, Wilmink JM, ten Berge IJ, Schellekens PT. Parlevliet KJ, et al. Among authors: wilmink jm. Transpl Int. 1995;8(2):141-6. doi: 10.1007/BF00344424. Transpl Int. 1995. PMID: 7766296 Clinical Trial.

5

Low-dose OKT3 induction therapy following renal transplantation: a controlled study.

Parlevliet KJ, ten Berge RJ, Raasveld MH, Surachno J, Wilmink JM, Schellekens PT. Parlevliet KJ, et al. Among authors: wilmink jm. Nephrol Dial Transplant. 1994;9(6):698-703. doi: 10.1093/ndt/9.6.698. Nephrol Dial Transplant. 1994. PMID: 7970099 Clinical Trial.

6

Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study.

Raasveld MH, Bloemena E, Wilmink JM, Surachno S, Schellekens PT, ten Berge RJ. Raasveld MH, et al. Among authors: wilmink jm. Transpl Int. 1993 Mar;6(2):89-94. doi: 10.1007/BF00336651. Transpl Int. 1993. PMID: 8383495

7

Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations.

Lardy NM, van der Horst AR, ten Berge IJ, Surachno S, Wilmink JM, de Waal LP. Lardy NM, et al. Among authors: wilmink jm. Transplantation. 1997 Aug 27;64(4):612-6. doi: 10.1097/00007890-199708270-00012. Transplantation. 1997. PMID: 9293875

8

Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil.

Levi M, Wilmink J, Büller HR, Surachno J, ten Cate JW. Levi M, et al. Transplantation. 1992 Dec;54(6):978-83. doi: 10.1097/00007890-199212000-00007. Transplantation. 1992. PMID: 1465791 Clinical Trial.

9

The influence of immunosuppressive treatment on immune responsiveness in vivo in kidney transplant recipients.

van der Heyden AA, Bloemena E, Out TA, Wilmink JM, Schellekens PT, van Oers MH. van der Heyden AA, et al. Among authors: wilmink jm. Transplantation. 1989 Jul;48(1):44-7. doi: 10.1097/00007890-198907000-00010. Transplantation. 1989. PMID: 2665234

10

Pretreatment with divided doses of steroids strongly decreases side effects of OKT3.

Bemelman FJ, Buysmann S, Surachno J, Wilmink JM, Schellekens PT, ten Berge IJ. Bemelman FJ, et al. Among authors: wilmink jm. Kidney Int. 1994 Dec;46(6):1674-9. doi: 10.1038/ki.1994.467. Kidney Int. 1994. PMID: 7700026 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters